Abstract Objective: Topical pretreatment with all-trans-retinoic acid (atRA) is known to improve healing of cutaneous wounds. We tested the effect of atRA on wound healing of genetically diabetic db/db mice. It is known that cutaneous wounds of db/db mice show delayed wound healing due to impaired wound contraction, delayed granulation tissue formation and underexpression of keratinocyte growth factor (KGF). Methods: 0.1% atRA in 100 mg aqueous gel was applied to the back skin of db/db mice as well as to their normal heterozygous littermates, db/+ mice, for five consecutive days, and 2 days after completion of the atRA treatment, two round excisional wounds were created down the panniculus carnosus with a 6-mm punch biopsy on the back skin of each mouse. Results: After 5 days treatment with 0.1% atRA, significant hypertrophy of the epidermis and dermis, neovascularization, and inflammatory cell invasion were seen in the skin of the db/db mice, but these effects were seen only weakly in db/+ mice. Wounds in atRA-treated db/db mice closed more rapidly than those in vehicle-treated db/db mice. KGF mRNA expression, which is usually significantly lower in db/db mice than in normal mice, in wounds of atRA-treated db/db mice on day 1 of treatment was as strong as in db/+ mice. Conclusion: Pretreatment with atRA reversed the impaired wound healing in db/db mice.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 9 March 2001 / Revised: 3 July 2001 / Accepted: 16 September 2001
Rights and permissions
About this article
Cite this article
Kitano, Y., Yoshimura, K., Uchida, G. et al. Pretreatment with topical all-trans-retinoic acid is beneficial for wound healing in genetically diabetic mice. Arch Dermatol Res 293, 515–521 (2001). https://doi.org/10.1007/PL00007466
Issue Date:
DOI: https://doi.org/10.1007/PL00007466